Christine is a serial entrepreneur, investor, founder and executive of several life sciences companies. She is a member of Launchpad Venture Group and a Founder of BuntAssociates LLC. BuntAssociates provides capital & executive staffing for start up companies in biotechnology and health care IT. Most recently, Christine has served as Chief Executive Officer and Chairman of the Board at Verseau Therapeutics. Prior to starting Verseau Therapeutics with Prof. Bob Langer and Prof. Dan Andersen from MIT, she was CEO and Founder of INTICA Biomedical (Personalized Medicine/Cancer) and TARIS Biomedical. TARIS Biomedical was cofounded with Prof. Michael Cima and Prof. Robert Langer from MIT (acquired by Allergan in 2014 for $588 million and by J&J in 2019 for an undisclosed amount). Previously, Christine was a Venture Partner with 2020HCP, a private investor group (exits: SQZ IPO, NYSE). Christine was an executive at Merck & Co, where she assumed various leadership positions, including worldwide commercialization for inflammation, neuroscience, and cardiovascular therapeutic products. Christine started her industry venture at Hoffmann-La Roche in Basel, Switzerland. She lead various R&D, business management, and commercialization functions for Roche Diagnostics. Christine holds degrees in Medical Technology and Immunochemistry (Biochemistry) from the Institute for Hygiene and Infectious Diseases/Medical School of the University of Saarbrücken, Germany. She mentors entrepreneurs and new technology startups at the MIT Deshpande Center. She continues to serve on various boards, including the BIDMC (Beth Israel Deaconess Medical Center) Board of Overseers and the HMS (Harvard Medical School) Institute for RNA Medicine.